Abrams P, Andersson KE, Birder L, Brubaker L, Cardozo L, Chapple C, et al.
Fourth International Consultation on Incontinence Recommendations of the International Scientific Committee: Evaluation and treatment of urinary incontinence, pelvic organ prolapse, and fecal incontinence.
Neurourol Urodyn 2010;29(1):213-40.
Abrams P, Cardozo L, Wein A.
The International Consultation on Incontinence, Research Society (ICI-RS).
Neurourol Urodyn 2010;29(4):596-7.
Abrams P, Khoury S.
International Consultation on Urological Diseases: Evidence-based medicine overview of the main steps for developing and grading guideline recommendations.
Neurourol Urodyn 2010;29(1):116-8.
Abrams PA, Fung SR.
Prey persistence and abundance in systems with intraguild predation and type-2 functional responses.
J Theor Biol 2010;264(3):1033-42.
Al-Hayek S, Abrams P.
The 50-year history of the ice water test in urology.
J Urol 2010;183(5):1686-92.
Astin JW, Batson J, Kadir S, Charlet J, Persad RA, Gillatt D, et al.
Competition amongst Eph receptors regulates contact inhibition of locomotion and invasiveness in prostate cancer cells.
Nat Cell Biol 2010;12(12):1194-204.
Ayres BE, Griffiths TR, Persad RA.
Is the role of intravesical bacillus Calmette-Guerin in non-muscle-invasive bladder cancer changing?
BJU Int 2010;105 Suppl 2:8-13.
Beresford MJ, Gillatt D, Benson RJ, Ajithkumar T.
A systematic review of the role of imaging before salvage radiotherapy for post-prostatectomy biochemical recurrence.
Clin Oncol (R Coll Radiol) 2010;22(1):46-55.
Birder L, de Groat W, Mills I, Morrison J, Thor K, Drake M.
Neural control of the lower urinary tract: peripheral and spinal mechanisms.
Neurourol Urodyn 2010;29(1):128-39.
Bright E, Oelke M, Tubaro A, Abrams P.
Ultrasound estimated bladder weight and measurement of bladder wall thickness--useful noninvasive methods for assessing the lower urinary tract?
J Urol 2010;184(5):1847-54.
Top
Bunce C, Ayres BE, Griffiths TR, Mostafid H, Kelly J, Persad R, et al.
The role of hexylaminolaevulinate in the diagnosis and follow-up of non-muscle-invasive bladder cancer.
BJU Int 2010;105 Suppl 2:2-7.
Chapple CR, Herschorn S, Abrams P, Wang JT, Brodsky M, Guan Z.
Efficacy and safety of tolterodine extended-release in men with overactive bladder symptoms treated with an alpha-blocker: effect of baseline prostate-specific antigen concentration.
BJU Int 2010;106(9):1332-8.
Crow P, Keeley FX.
Prevention and handling of complications of renal focal therapies.
J Endourol 2010;24(5):765-7.
Davenport K, Keeley FX, Jr., Timoney AG.
Audit of safety, efficacy, and cost-effectiveness of local anaesthetic cystodiathermy.
Ann R Coll Surg Engl 2010;92(8):706-9.
Davenport K, Kumar V, Collins J, Melotti R, Timoney AG, Keeley FX, Jr.
New ureteral stent design does not improve patient quality of life: a randomized, controlled trial.
J Urol 2011;185(1):175-8.
De Gennaro M, Niero M, Capitanucci ML, von Gontard A, Woodward M, Tubaro A, et al.
Validity of the international consultation on incontinence questionnaire-pediatric lower urinary tract symptoms: a screening questionnaire for children.
J Urol 2010;184(4 Suppl):1662-7.
Dellis A, Joshi HB, Timoney AG, Keeley FX, Jr.
Relief of stent related symptoms: review of engineering and pharmacological solutions.
J Urol 2010;184(4):1267-72.
Drake MJ, Fowler CJ, Griffiths D, Mayer E, Paton JF, Birder L.
Neural control of the lower urinary and gastrointestinal tracts: supraspinal CNS mechanisms.
Neurourol Urodyn 2010;29(1):119-27.
Drake MJ, Tannenbaum C, Kanai AJ.
Potential insights into lower urinary function derived from CNS imaging.
Neurourol Urodyn 2010;29(4):629-33.
Evans S, Metcalfe C, Patel B, Ibrahim F, Anson K, Chinegwundoh F, et al.
Clinical presentation and initial management of black men and white men with prostate cancer in the United Kingdom: the PROCESS cohort study.
Br J Cancer 2010;102(2):249-54.
Fry CH, Daneshgari F, Thor K, Drake M, Eccles R, Kanai AJ, et al.
Animal models and their use in understanding lower urinary tract dysfunction.
Neurourol Urodyn 2010;29(4):603-8.
Gajewski J, Drake MJ, Oelke M.
Post-prostatectomy stress urinary incontinence: what treatment for which patient?
Neurourol Urodyn 2010;29(4):679-83.
Gao W, Romkes M, Zhong S, Nukui T, Persad RA, Smith PJ, et al.
Genetic polymorphisms in the DNA repair genes XPD and XRCC1, p53 gene mutations and bladder cancer risk.
Oncol Rep 2010;24(1):257-62.
Gulur DM, Drake MJ.
Management of overactive bladder.
Nat Rev Urol 2010;7(10):572-82.
Hashim H, Abrams P.
Emerging drugs for the treatment of benign prostatic obstruction.
Expert Opin Emerg Drugs 2010;15(2):159-74.
Henderson E, Drake M.
Overactive bladder.
Maturitas 2010;66(3):257-62.
Herschorn S, Bruschini H, Comiter C, Grise P, Hanus T, Kirschner-Hermanns R, et al.
Surgical treatment of stress incontinence in men.
Neurourol Urodyn 2010;29(1):179-90.
Hotston M, Jeremy JY, Persad R, Bloor J, Shukla N.
8-isoprostane F2alpha up-regulates the expression of type 5 phosphodiesterase in cavernosal vascular smooth muscle cells: inhibition with sildenafil, iloprost, nitric oxide and picotamide.
BJU Int 2010;106(11):1794-8.
Jones R, Abrams P, Hilton P, Ward K, Drake M.
Risk of tape-related complications after TVT is at least 4%.
Neurourol Urodyn 2010;29(1):40-1.
Lallas CD, Pak RW, Pagnani C, Hubosky SG, Yanke BV, Keeley FX, et al.
The minimally invasive management of ureteropelvic junction obstruction in horseshoe kidneys.
World J Urol 2010 Mar 5. [Epub ahead of print]
Mason K, Cottrell AM, Corrigan AG, Gillatt DA, Mitchelmore AE.
Ketamine-associated lower urinary tract destruction: a new radiological challenge.
Clin Radiol 2010;65(10):795-800.
McVey GP, McPhail S, Fowler S, McIntosh G, Gillatt D, Parker CC.
Initial management of low-risk localized prostate cancer in the UK: analysis of the British Association of Urological Surgeons Cancer Registry.
BJU Int 2010;106(8):1161-4.
Mevcha A, Drake MJ.
Etiology and management of urinary retention in women.
Indian J Urol 2010;26(2):230-5.
Mevcha A, Gulur DM, Gillatt D.
Diagnosing urological disorders in ageing men.
Practitioner 2010;254(1726):25-6, 28-9, 2-3.
Mostafid H, Persad R, Kockelbergh R, Fawcett D.
Is it time to re-design the haematuria clinic?
BJU Int 2010;105(5):585-8.
Phipps S, Tolley DA, Young JG, Keeley FX, Jr.
The management of ureteric stones.
Ann R Coll Surg Engl 2010;92(5):368-72.
Ranasinghe WK, Wright T, Attia J, McElduff P, Doyle T, Bartholomew M, et al.
Effects of bariatric surgery on urinary and sexual function.
BJU Int 2011;107(1):88-94.
Shaban A, Drake MJ, Hashim H.
The medical management of urinary incontinence.
Auton Neurosci 2010;152(1-2):4-10.
Swithinbank LV, Heron J, von Gontard A, Abrams P.
The natural history of daytime urinary incontinence in children: a large British cohort.
Acta Paediatr 2010;99(7):1031-6.
Thomas F, Holly JM, Persad R, Bahl A, Perks CM.
Fibronectin confers survival against chemotherapeutic agents but not against radiotherapy in DU145 prostate cancer cells: involvement of the insulin like growth factor-1 receptor.
Prostate 2010;70(8):856-65.
Thuroff JW, Abrams P, Andersson KE, Artibani W, Chapple CR, Drake MJ, et al.
EAU Guidelines on Urinary Incontinence.
Eur Urol 2010 Nov 24. [Epub ahead of print]
Top
Aning J, Neal D, Driver A, McGrath J.
Enhanced recovery: from principles to practice in urology.
BJU Int 2010;105(9):1199.
Edwards TJ, Dickinson AJ, Gosling J, McInerney PD, Natale S, McGrath JS.
Patient-specific risk of undetected malignant disease after investigation for haematuria, based on a 4-year follow-up.
BJU Int 2011;107(2):247.
Pisipati P, Pearcy R.
The role of urological surgery in male infertility.
Hum Fertil (Camb) 2010;13(4):233.
Kotwal S, Munro N.
Radiotherapy in localized bladder cancer: what is the evidence?
Current Opinion in Urology 2010;20(5):426.
Kumaraswamy P, Cox R, O'Rourke JS, Willis RG
Audit of two-week rule referrals for suspected testicular cancer in Cornwall, 2003-2005.
Ann R Coll Surg Engl 2009;91(3):239.
Munro NP, Stower MJ, Urwin GH, Chan KH, Wilson JR.
Three-year outcomes of a visible haematuria clinc - no initial role for urine cytology?
BJMSU 2010;3(5):204.
Top
BAUS publications
